“Thrombosis after vaccination of AstraZeneca, EMA’cautionary symptom'”

Input 2021.03.20 15:24

The quarantine authorities announced on the 20th that it is the European Medicines Agency’s (EMA) vaccination’cautions’ for those in their twenties whose brain blood clots were found after receiving AstraZeneca (AZ)’s coronavirus infection (Corona 19) vaccine.

Park Young-joon, head of the adverse reaction investigation support team of the Corona Vaccination Response Promotion Team, said, “The result of magnetic resonance imaging (MRI) was confirmed as a cerebral vein thrombosis, and the findings that cerebral venous sinus thrombosis (CVST) could be suspected.” said.

Venous sinus thrombosis is one of the cases that the European Medicines Agency said it would analyze further without excluding its association with AstraZeneca vaccination. However, the European Medicines Agency has tentatively concluded that the AstraZeneca vaccine is not associated with an increased overall risk of blood clots.

“We are currently testing the causative agent,” said Park, and said, “We will evaluate the relevance (with vaccination) through a review of the provincial rapid response team and the damage investigation team (if the results are available).”

The quarantine authorities have not ruled out the very rare causality between the AstraZeneca vaccine and the occurrence of thrombosis by the European Medicines Agency, but there is currently no plan to change the vaccination schedule. “We are planning to proceed with vaccination according to the existing vaccination plan for the second quarter, according to the vaccination plan for the second quarter,” said Byeong-taek Bae, head of the promotion group.